Rhodomyrtosone D

Overview

Rhodomyrtosone D is a natural α-glucosidase and BCL-2 inhibitor. Rhodomyrtosone D exhibits an IC 50 of 110.45 μg/mL against α-glucosidase derived from Saccharomyces cerevisiae . Rhodomyrtosone D interferes with carbohydrate digestion, interacts with specific BCL-2 amino acid residues, and reduces postprandial blood glucose levels. Rhodomyrtosone D can be used in the research of diabetes and breast cancer .

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Breast Cancer | Products > Disease Areas > Glucose Metabolism | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Metabolic Disease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Glycosidase | Products > Signaling Pathways > Bcl-2 Family

Product Information

• Catalog No.: HY-N19904
• CAS No.: 1079988-19-4
• Molecular Formula: C25H32O6
• Molecular Weight: 428.52
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source